This subpart sets forth the requirements relating to the following:
(a) Drug utilization management programs, quality assurance measures and systems, and MTM programs for Part D sponsors.
(b) Appropriate dispensing of prescription drugs in long-term care facilities under PDPs and MA-PD plans.
(c) Consumer satisfaction surveys of Part D plans.
(d) Electronic prescription drug programs for prescribers, dispensers, and Part D sponsors.
(e) Quality improvement organization (QIO) activities.
(f) Compliance deemed on the basis of accreditation.
(g) Accreditation organizations.
(h) Procedures for the approval of accreditation organizations as a basis for deeming compliance.
[70 FR 4525, Jan. 28, 2005, as amended at 70 FR 67593, Nov. 7, 2005; 76 FR 21573, Apr. 15, 2011; 89 FR 30834, Apr. 23, 2024]